Ceidos SA
Ceidos has developed a machine that automates the production of cell therapies, which are used in particular as a treatment for cancer.
BrainElem Sàrl
To facilitate teaching and learning at all ages, we develop solutions, which are driven by neuroscience findings, to enrich and maximize the learning capacity of the human brain.
IHMA Europe Sàrl
Leading provider of antimicrobial drug development support services for clients around the world. IHMA provides a full suite of technical capabilities and domain expertise in all phases of antimicrobial drug development: drug discovery, clinical development, regulatory approval and commercialization.
ImmunSkills SA
ImmunSkills SA is a company active in the field of cell therapy. Its objective is to improve the effectiveness of treatments for solid cancers by developing a new product based on allogenic cells.
REM Analytics
Advanced Testing for Genetic Composition (ATGC) that can be applied in food safety, cosmetics and agriculture
Inflamalps SA
Inflamalps is a company that develops new substances capable of fighting certain inflammatory diseases of the eye and in particular dry eye disease and uveitis.
Swiss Biotech Center SA
Swiss Biotech Center is a company that acts as a competence center open to innovative companies and academic researchers and developers.
Sunchemical
Monthey is home to the production of high performance organic pigments. The pigments are used for colouring paints, plastics, inks, synthetic fibres, as well as in electronic applications such as colour filters for liquid crystal displays.
Orio Therapeutics
Orio Therapeutics is developing an innovative technology that modifies therapeutic proteins to improve delivery through controlled localization for increased efficacy and reduced dose. Today, Orio Therapeutics is focused on developing therapies for patients with myocardial infarction. However, it remains capable of modifying any protein-based therapy with its technology
Novochizol SA
Researches and develops applications of Novochizol, a unique chitosan nanoparticle technology that yields different carriers of small molecules, peptides, nucleic acids and proteins for sustained, localized delivery to any living tissue, with intracellular targeting potential.
